The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
The move signals a major expansion in access to next-generation weight-loss therapies
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
The technology enables clinicians to assess brain tissue and microvascular reperfusion directly in the angiography suite, potentially improving stroke treatment decisions and patient outcomes
While oncology contributed Rs. 16,100.9 million to remain company's largest therapy area, the key highlight was receipt of 11 new regulatory approvals for medicines and indications
The programme evaluated anselamimab as a first-line add-on to standard plasma cell dyscrasia therapy in patients with advanced cardiac AL amyloidosis
The move marks one of the most significant coverage expansions yet in obesity care, bringing FDA-approved treatment options further into mainstream insurance plans rather than out-of-pocket reach
Subscribe To Our Newsletter & Stay Updated
